Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Exploring Common Therapeutic Targets for Neurodegenerative Disorders Using Transcriptome Study

19 Mar 2021

Abstract excerpt

Alzheimer's disease (AD) and Parkinson's disease (PD) are well-known neuronal degenerative disorders that share common pathological events. Approved medications alleviate symptoms but do not address the root cause of the disease. Energy dysfunction in the neuronal population leads to various pathological events and ultimately results in neuronal death. Identifying common therapeutic targets for these disorders...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Bioinformatics and Genomic Networks
Share to Epigenetics and DNA Methylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33815473
DOI: 10.3389/fgene.2021.639160

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Exploring Common Therapeutic Targets for Neurodegenerative Disorders Using Transcriptome StudyPMID 33815473Read ↗

A multi-omics dataset for the analysis of frontotemporal dementia genetic subtypes.Semantic proximity Read ↗

Common Dysregulated Pathways and Genes in Alzheimer’s, Parkinson’s, and Huntington’s Diseases: A Computational Analysis to Nominate Candidate Gene Targets for Drug RepurposingSemantic proximity Read ↗

A multi-omics dataset for the analysis of Frontotemporal Dementia genetic subtypesSemantic proximity Read ↗

Integrated multi-omics analysis reveals common and distinct dysregulated pathways for genetic subtypes of Frontotemporal DementiaSemantic proximity Read ↗

Identification of Common Molecular Signatures Shared between Alzheimer’s and Parkinson’s Diseases and Therapeutic Agents Exploration: An Integrated Genomics ApproachSemantic proximity Read ↗

Identification of common molecular biomarker signatures in blood and brain of Alzheimer’s diseaseSemantic proximity Read ↗

Identification of molecular signatures associated with sleep disorder and Alzheimer’s diseaseSemantic proximity Read ↗

A genome-wide screening and SNPs-to-genes approach to identify novel genetic risk factors associated with frontotemporal dementia.Semantic proximity Read ↗

Genome-scale transcriptional regulatory network models of psychiatric and neurodegenerative disordersSemantic proximity Read ↗

Predicting brain-regional gene regulatory networks from multi-omics for Alzheimer's disease phenotypes and Covid-19 severity.Semantic proximity Read ↗

Single-cell multiomics reveals disrupted glial gene regulatory programs in Alzheimer’s disease via interpretable machine learningSemantic proximity Read ↗

Potential hippocampal genes and pathways involved in Alzheimer’s disease: a bioinformatic analysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.